# DENND2A

## Overview
DENND2A is a gene that encodes the protein DENN domain containing 2A, which is categorized as a guanine nucleotide exchange factor (GEF) for Rab GTPases. This protein plays a crucial role in intracellular signaling and membrane trafficking, particularly in the transport of vesicles and the regulation of endocytosis and exocytosis. The DENN domain within the protein facilitates its function as a GEF, specifically targeting RAB9A and RAB9B GTPases, which are vital for the movement of materials within cells and between cellular compartments (Zhang2020CircDENND2A). DENND2A is active in the cytoplasm and is involved in key cellular processes such as growth, differentiation, and migration. It also plays a significant role in the transport from late endosomes to the trans-Golgi network, which is essential for maintaining cellular homeostasis (Zhang2020CircDENND2A). Beyond its fundamental cellular functions, DENND2A has been implicated in various diseases, including congenital heart disease, intellectual disability, ischemic stroke, Parkinson's disease, and certain cancers, highlighting its clinical significance (Wu2022Identifying; Zhang2020CircDENND2A; Lang2019Identification).

## Function
DENND2A is a gene that encodes a protein involved in intracellular signaling and membrane trafficking. The protein contains a DENN domain, which functions as a guanine nucleotide exchange factor (GEF) for Rab GTPases, specifically RAB9A and RAB9B. These GTPases are essential for vesicle transport, endocytosis, and exocytosis in cells, facilitating the movement of materials within the cell and between cellular compartments (Zhang2020CircDENND2A). DENND2A is active in the cytoplasm and plays a role in regulating cellular processes such as cell growth, differentiation, and migration. It is involved in transport from late endosomes to the trans-Golgi network, a critical pathway for maintaining cellular homeostasis and function (Zhang2020CircDENND2A).

In the context of viral infections, DENND2A has been implicated in the maintenance of hepatitis B virus (HBV) within host cells. It is expressed at higher levels in HBV-infected cells, and its knockdown significantly reduces HBV DNA and covalently closed circular DNA (cccDNA) levels, suggesting a role in viral replication and persistence (Hashimoto2021DOCK11). However, the specific function of DENND2A in healthy human cells beyond its role in intracellular transport and signaling is not fully detailed in the available literature.

## Clinical Significance
Mutations and alterations in the expression of the DENND2A gene have been implicated in several diseases. In the context of congenital heart disease (CHD) and intellectual disability, DENND2A has been identified as a significant gene, with mutations linked to these conditions (Wu2022Identifying). The gene is also associated with ischemic stroke and Parkinson's disease, where it may play a role in mitophagy, a process important for cellular health and implicated in these diseases (Lang2019Identification).

In cancer research, DENND2A appears to have a dual role. In non-small cell lung cancer (NSCLC), the circular RNA form of DENND2A, known as circDENND2A, is up-regulated and promotes cancer progression, while the linear form of DENND2A is down-regulated and may act as a tumor suppressor (Zhang2020CircDENND2A). This suggests that DENND2A's expression levels and forms can influence cancer outcomes.

DENND2A is also involved in the maintenance of hepatitis B virus (HBV) within host cells. Knockdown of DENND2A in infected cells leads to a reduction in HBV DNA, indicating its role in viral persistence (Hashimoto2021DOCK11). These findings highlight the gene's clinical significance across a range of diseases.


## References


[1. (Wu2022Identifying) Yiming Wu, Cigdem Sevim Bayrak, Bosi Dong, Shixu He, Peter D. Stenson, David N. Cooper, Yuval Itan, and Lei Chen. Identifying shared genetic factors underlying epilepsy and congenital heart disease in europeans. Human Genetics, 142(2):275–288, November 2022. URL: http://dx.doi.org/10.1007/s00439-022-02502-4, doi:10.1007/s00439-022-02502-4. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-022-02502-4)

[2. (Zhang2020CircDENND2A) Yinbin Zhang, Changyou Shan, Yinxi Chen, Shiyu Sun, Di Liu, Xin Zhang, and Shuqun Zhang. Circdennd2a promotes non-small cell lung cancer progression via regulating mir-34a/ccne1 signaling. Frontiers in Genetics, September 2020. URL: http://dx.doi.org/10.3389/fgene.2020.00987, doi:10.3389/fgene.2020.00987. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.00987)

[3. (Lang2019Identification) Wenjing Lang, Junjie Wang, Xiaofeng Ma, Nong Zhang, He Li, Pan Cui, and Junwei Hao. Identification of shared genes between ischemic stroke and parkinson’s disease using genome-wide association studies. Frontiers in Neurology, March 2019. URL: http://dx.doi.org/10.3389/fneur.2019.00297, doi:10.3389/fneur.2019.00297. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2019.00297)

[4. (Hashimoto2021DOCK11) Shinichi Hashimoto, Takayoshi Shirasaki, Taro Yamashita, Sadahiro Iwabuchi, Yutaka Suzuki, Yuzuru Takamura, Yoshiaki Ukita, Shungo Deshimaru, Toshitugu Okayama, Kazuho Ikeo, Kazuyuki Kuroki, Kazunori Kawaguchi, Eishiro Mizukoshi, Kouji Matsushima, Masao Honda, and Shuichi Kaneko. Dock11 and dennd2a play pivotal roles in the maintenance of hepatitis b virus in host cells. PLOS ONE, 16(2):e0246313, February 2021. URL: http://dx.doi.org/10.1371/journal.pone.0246313, doi:10.1371/journal.pone.0246313. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0246313)